| Literature DB >> 28830451 |
Ergibnesh Getahun1, Baye Gelaw2, Abate Assefa1, Yared Assefa3, Anteneh Amsalu1.
Abstract
BACKGROUND: External ocular infection is a public health problem in Ethiopia. The aim of this study was to determine the prevalence and antimicrobial susceptibility pattern of external ocular bacterial infections.Entities:
Keywords: External ocular infections; MRSA; Multidrug resistance; Staphylococcus Aureus
Mesh:
Substances:
Year: 2017 PMID: 28830451 PMCID: PMC5567627 DOI: 10.1186/s12886-017-0548-6
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Possible risk factors and their association with the prevalence of bacterial infection among patients with external ocular infection at University of Gondar hospital, Northwest Ethiopia, 2016
| Variables | Culture results | COR (95% CI) | AOR(95% CI) |
| |||
|---|---|---|---|---|---|---|---|
| n (%) | -ve n (%) | +ve n (%) | |||||
| Previous ocular infection | Yes | 215(68.9) | 81(37.7) | 134(62.3) | 1.69(1.041–2.74) | ||
| No | 97(31.1) | 49(50.5) | 48(49.5) | 1 | |||
| Previous use of antimicrobials | Yes | 147(47.1) | 49 (33.3) | 98(66.7) | 1.93(1.219–3.05) | 1.84(1.132–2.97) | 0.014 |
| No | 165(52.9) | 81(49.1) | 84(50.9) | 1 | 1 | ||
| History of surgery | Yes | 46(14.7) | 19(41.3) | 27(58.7) | 1.02(0.539–1.92) | ||
| No | 266(93.6) | 111(41.7) | 155(58.3) | 1 | |||
| Duration of present illness | <1 week | 107(34.3) | 52(48.6) | 55(51.4) | 1 | 1 | |
| 2–4 weeks | 33(10.6) | 9(27.3) | 24(72.7) | 2.52(1.072–5.93) | 2.72(1.116–6.62) | 0.028 | |
| >4 weeks | 172(55.1) | 69(40.1) | 103(59.9) | 1.41(0.868–2.29) | 1.26(0.754–2.12) | 0.34 | |
| Ocular trauma | Yes | 57(18.3) | 30(52.6) | 27(47.4) | 1 | ||
| No | 255(81.7) | 100(39.2) | 155(60.8) | 1.72(0.967–3.068) | |||
n number of patients, −ve negative, +ve positive, COR crude odds ratio, AOR adjusted odds ratio
Distribution of bacterial isolates among different clinical features of external ocular infections at University of Gondar hospital, Northwest Ethiopia, 2016
| Bacteria species | Clinical features with total bacteria isolated | |||||
|---|---|---|---|---|---|---|
| Conjunctivitis | Blepharitis | Dacryocystitis | Keratitis | Blepharo-conjunctivitis ( | Total ( | |
|
| 46(51.1) | 40(50.6) | 7(50) | 3(50) | 0 | 96(50.3) |
| CoNS | 28(31.1) | 26(32.9) | 7(50) | 2(33.3) | 1(50) | 64(33.5) |
|
| 3(3.3) | 4(5.1) | 0 | 0 | 1(50) | 8(4.2) |
|
| 5(5.6) | 4(5.1) | 0 | 0 | 0 | 9(4.7) |
|
| 4(4.4) | 1(1.3) | 0 | 1(16.7) | 0 | 6(3.1) |
|
| 0 | 2(2.5) | 0 | 0 | 0 | 2(1.0) |
|
| 1(1.1) | 0 | 0 | 0 | 0 | 1(0.5) |
|
| 2(2.2) | 0 | 0 | 0 | 0 | 2(1.0) |
|
| 1(1.1) | 2(2.5) | 0 | 0 | 0 | 3(1.6) |
| Total | 90(47.1) | 79(41.4) | 14(7.3) | 6(3.1) | 2(1) | 191(100) |
Antimicrobial susceptibility pattern of Gram positive bacterial isolates of external ocular infections at University of Gondar hospital, Northwest Ethiopia, 2016
| Antimicrobials | Gram positive bacteria S or R n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
| Total, | |||||
| S (%) | R (%) | S(%) | R(%) | S(%) | R(%) | S(%) | R(%) | |
| SXT | 89(92.7) | 7(7.3) | 49(76.6) | 15(23.4) | 8(100) | 0 | 146 (86.9) | 22 (13.1) |
| TE | 70(72.9) | 26(27.1) | 43(67.2) | 21(32.8) | 5(62.5) | 3(37.5) | 118(70.2) | 50(29.8) |
| P | 3(3.1) | 93(96.9) | 3(4.7) | 61(95.3) | 8(100) | 0 | 14(8.3) | 154(91.7) |
| C | 85(88.5) | 11(11.5) | 54(84.4) | 10(15.6) | 7(77.5) | 1(12.5) | 147(87.5) | 21(12.5) |
| E | 69(71.9) | 27(28.1) | 37(57.8) | 27(42.2) | 8(100) | 0 | 114(67.9) | 54 (32.1) |
| DA | 89(92.7) | 7(7.3) | 61(95.3) | 3(4.7) | 5(62.5) | 3(37.5) | 155(92.3) | 13(7.7) |
| CXT | 73(76) | 23(24) | 40(62.5) | 24(37.5) | - | - | 113(70.6) | 47(29.4) |
| CRO | 75(78.1) | 20(20.8) | 53(82.8) | 11(17.2) | 8(100) | 0 | 136(81.0) | 32(19.0) |
| CIP | 89(92.7) | 7(7.3) | 57(89.1) | 7(10.9) | - | - | 146(91.2) | 14(8.8) |
| CFP | 95(99) | 1(1) | 64(100) | 0 | 8(100) | 0 | 167(99.4) | 1(0.6) |
| CN | 69(71.9) | 27(28.1) | 47(73.4) | 17(26.6) | - | - | 116(72.5) | 44(27.5) |
| AMP | 7(7.3) | 89(92.7) | 7(10.9) | 57(89.1) | 8(100) | 0 | 22(13.1) | 146(86.9) |
| AML | 7(7.3) | 89(92.7) | 7(10.9) | 57(89.1) | 8(100) | 0 | 22(13.1) | 146(86.9) |
| AMC | 79(82.3) | 17(17.7) | 53(82.8) | 11(17.2) | 8(100) | 0 | 140(83.3) | 28(16.7) |
| CAZ | 13(13.5) | 83(86.5) | 11(17.2) | 53(89.1) | 8(100) | 0 | 32(19.0) | 136(81.0) |
| OX | 69(71.9) | 27(28.1) | 40(62.5) | 24(37.5) | - | - | 109(68.1) | 51(31.9) |
SXT Cotrimoxazole, TE Tetracycline, P Penicillin, C Chloramphenicol, E Erythromycin, DA Clindamycin, CXT cefoxitin, CRO Ceftriaxone, CIP Ciprofloxacin, CFP cefepime, CN Gentamicin, AMP Ampicillin, AML amoxicillin, AMC Amoxicillin-clavulanate, CAZ ceftazidime, OX oxacillin, S/R Sensitive or resistant
Antimicrobial susceptibility pattern of Gram negative bacterial isolates of external ocular infections at University of Gondar hospital, Northwest Ethiopia, 2016
| Antimicrobials | Gram negative bacteria S, or R, n (%) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Klebsiella spp. ( |
| Entrobacter | Seratia spp. ( | Proteus spp. ( |
| Total ( | ||||||||
| S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | |
| SXT | 6(66.7) | 3(33.3) | 6(100) | 0 | 2(66.7) | 1(33.3) | 1(50) | 1(50) | 2(100) | 0 | 1(100) | 0 | 18(78.3) | 5(21.7) |
| TE | 6(66.7) | 3(33.3) | 4(66.7) | 2(33.3) | 1(33.3) | 2(66.7) | 2(100) | 0 | 1(50) | 1(50) | 1(100) | 0 | 15(65.2) | 8(34.8) |
| CAZ | 5(55.6 | 4(44.4) | 5(83.3) | 1(16.7) | 3(100) | 0 | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 18(78.3) | 5(21.7) |
| C | 5(55.6) | 4(44.4) | 4(66.7) | 2(33.3) | 3(100) | 0 | 2(100) | 0 | 1(50) | 1(50) | 1(100) | 0 | 16(69.6) | 7(30.4) |
| CIP | 7(77.8) | 2(22.2) | 5(83.3) | 1(16.7) | 3(100) | 0 | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 20(87.0) | 3(13) |
| CXT | 7(77.8) | 2(22.2) | 5(83.3) | 1(16.7) | 3(100) | 0 | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 20(87.0) | 3(13) |
| CRO | 6(66.7) | 3(33.3) | 5(83.3) | 1(16.7) | 2(66.7) | 1(33.3) | 1(50) | 1(50) | 2(100) | 0 | 1(100) | 0 | 17(73.9) | 6(26.1) |
| CFP | 7(77.8) | 2(22.2) | 6(100) | 0 | 3(100) | 0 | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 21(91.3) | 2(8.7) |
| CN | 6(66.7) | 3(33.3) | 4(66.7) | 2(33.3) | 3(100) | 0 | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 18(78.3) | 5(21.7) |
| AMP | 0 | 9(100) | 3(50) | 3(50) | 2 (66.7) | 1(33.3) | 2(100) | 0 | 2 (100) | 0 | 1(100) | 10(43.5) | 13(56.5) | |
| AML | 0 | 9(100) | 3(50) | 3(50) | 2(66.7) | 1(33.3) | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 10(43.5) | 13(56.5) |
| AMC | 8(88.9) | 1(11.1) | 5(83.3) | 1(16.7) | 2(66.7) | 1(33.3) | 2(100) | 0 | 2(100) | 0 | 1(100) | 0 | 20(87.0) | 3(13.0) |
SXT cotrimoxazole, TE Tetracycline, CAZ ceftazidime, C Chloramphenicol, CIP Ciprofloxicin, CXT cefoxitin, CRO Ceftriaxone, CFP cefepime, CN Gentamicin, AMP Ampcillin, AML amoxicilline, AMCAmoxicillin-clavulanate
Multidrug resistance patterns of bacterial isolates from external ocular infection at University of Gondar hospital, Northwest Ethiopia, 2016
| Types of bacteriaisolates | Total bacteria | Antimicrobial resistance pattern | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R0 | R1 | R2 | R3 | R4 | R5 | R6 | R7 | R8 | ||
|
| 96(50.3) | 0 | 0 | 3(3.1) | 2(2.1) | 26(27.1) | 19(19.8) | 15(15.6) | 11(11.5) | 20(20.8) |
| CoNS | 64(33.5) | 1(1.6) | 1(1.6) | 2(3.1) | 2(3.1) | 8(12.5) | 20(31.3) | 4(6.3) | 2(3.1) | 24(37.5) |
|
| 8(4.2) | 2(25) | 5(62.5) | 1(12.5) | 0 | 0 | 0 | 0 | 0 | 0 |
| Klebsella spp | 9(4.7) | 0 | 0 | 1(11.1) | 1(11.1) | 2(22.2) | 2(22.2) | 2(22.2) | 0 | 1(11.1) |
|
| 6(3.1) | 2(33.3) | 1(16.7) | 1(16.7) | 0 | 2(33.3) | 0 | 0 | 0 | |
| Entrobacter spp. | 3(1.6) | 0 | 0 | 2(66.7) | 1(33.3) | 0 | 0 | 0 | 0 | 0 |
| Serratia spp. | 2(1) | 1(50) | 1(50) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Proteus spp. | 2(1) | 1(50) | 0 | 0 | 1(50) | 0 | 0 | 0 | 0 | 0 |
| Citrobacter spp. | 1(0.5) | 1(100) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 191(61.2) | 8(4.2) | 7(3.7) | 10(5.2) | 8(4.2) | 36(18.8) | 43(22.5) | 21(11) | 13(6.8) | 45(23.6) |
CoNS* = Coagulase negative staphylococci;R0 = sensitive to all antimicrobials;R1 = resistant to 1antimicrobial; R2 = resistant to2antimicrobials;R3 = resistant to 3antimicrobials;R4 = resistant to 4antimicrobials;R5 = resistant to 6antimicrobials;R7 = resistant to7antimicrobials;R8 = resistant to 8antimicrobials; Spp. = species